FI CLASS ACTION NOTICE: Berger Montague Encourages Fiserv, Inc. (FI) Investors to Inquire About a Securities Fraud Class Action
Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - National plaintiffs' law firm Berger Montague PC is investigating potential claims against Fiserv, Inc. (NYSE: FI) ("Fiserv" or the "Company") related to alleged securities law violations. This investigation follows the filing of a securities class action lawsuit against Fiserv and certain of its senior executives on behalf of investors who purchased the Company's securities between July 24, 2024 and July 22, 2025 (the "Class...
2025-08-25 10:18 AM EDT
ATTENTION RXSIGHT (RXST) SHAREHOLDERS: Securities Fraud Lawsuit Filed Against RxSight, Inc
Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - Berger Montague PC, a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST), following the recent filing of a federal securities class action lawsuit. The lawsuit alleges that Defendants failed to disclose to investors that: (1) RxSight was experiencing "adoption challenges" and/or structural issues resulting in...
2025-08-25 10:09 AM EDT
INVESTOR REMINDER: Berger Montague Notifies CTO Realty Growth, Inc. (CTO) Investors of a Class Action Lawsuit and Deadline
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of CTO between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities during the Class Period may, no later than...
2025-08-22 5:41 PM EDT
Altimmune, Inc. (ALT) Securities Fraud: Contact Berger Montague To Discuss Your Rights
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis) after a class action lawsuit was filed against Altimmune. Investor Deadline: Investors who purchased or...
2025-08-22 10:52 AM EDT
SPECTRUM PHARMACEUTICALS (SPPI) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Spectrum securities during the Class Period...
2025-08-22 10:47 AM EDT
INVESTOR ALERT: Berger Montague Advises Sable Offshore Corp. (SOC) Investors to Inquire About a Securities Fraud Class Action by September 26, 2025
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Sable Offshore Corp. (NYSE: SOC) ("Sable" or the "Company") following the filing of a securities class action lawsuit. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Sable securities between May 19, 2025 through June 3, 2025 (the "Class Period"), as well as on or traceable to the Company's May 2025...
2025-08-21 5:46 PM EDT
CTO INVESTOR ALERT: Berger Montague Advises CTO Realty Growth, Inc. Investors of an October 7, 2025 Deadline
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") following the filing of a securities class action lawsuit on behalf of investors who purchased or otherwise acquired CTO securities between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities...
2025-08-21 5:36 PM EDT
SHAREHOLDER ALERT: Berger Montague Reminds Novo Nordisk A/S (NVO) Investors of Class Action Lawsuit Deadline
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Novo from May 7, 2025 through July 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Novo securities during the Class Period may, no later than September 30,...
2025-08-21 5:16 PM EDT
Berger Montague Reminds Petco Health and Wellness Company, Inc. (WOOF) Investors with Substantial Losses to Inquire About a Securities Fraud Class Action by August 29, 2025
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague, a national securities litigation law firm announces it is investigating potential securities fraud claims involving Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF), following the recent filing of a federal securities class action lawsuit. The complaint alleges that Petco made false and misleading statements about the sustainability of its pandemic-driven growth and premium...
2025-08-21 5:06 PM EDT
SHAREHOLDER ALERT: Berger Montague Reminds Fiserv, Inc. (FI) Investors of Class Action Lawsuit Deadline
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Fiserv, Inc. (NYSE: FI) ("Fiserv" or the "Company") following the filing of a securities class action lawsuit. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Fiserv securities between July 24, 2024 and July 22, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Fiserv...
2025-08-21 11:46 AM EDT
RXSIGHT (RXST) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). A class action lawsuit was recently filed on behalf of investors who acquired RxSight securities between November 7, 2024 and July 8, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired RxSight securities...
2025-08-21 11:36 AM EDT
DEADLINE NEXT WEEK: Berger Montague Advises Hims & Hers Health Inc. (HIMS) Investors to Contact the Firm Before August 25, 2025
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague announces a securities fraud investigation into Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) concerning potential violations of the Securities Exchange Act of 1934. The inquiry focuses on whether investors were misled about the Company's regulatory compliance and business operations. Following Novo Nordisk's termination of its collaboration with Hims & Hers on June 23, 2025, the Company's...
2025-08-21 11:22 AM EDT
CLASS ACTION REMINDER: Berger Montague Advises Spectrum Pharmaceuticals (SPPI) Investors to Inquire About a Securities Fraud Lawsuit by September 24, 2025
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Spectrum securities during the Class Period...
2025-08-20 9:06 PM EDT
CLASS ACTION NOTICE: Berger Montague Advises Altimmune, Inc. (ALT) Investors to Inquire About a Securities Fraud Class Action
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") following the filing of a securities class action lawsuit filed on behalf of investors who purchased or otherwise acquired Altimmune securities between August 10, 2023 through June 25, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired...
2025-08-20 5:21 PM EDT
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against KinderCare Learning Companies, Inc. (KLC)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - Berger Montague PC is investigating claims under the federal securities laws against KinderCare Learning Companies, Inc. (NYSE: KLC) ("KinderCare" or the "Company"), a provider of early childhood education and childcare services, after a class action lawsuit was filed against KinderCare. Investor Deadline: Investors who purchased or acquired KinderCare securities between October 6, 2024 to August 12, 2025 (the "Class Period"),...
2025-08-20 4:52 PM EDT
CTO Realty Growth, Inc. (CTO) Securities Fraud: Contact Berger Montague to Discuss Your Rights
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - Berger Montague PC is investigating claims under the federal securities laws against CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company"), a real estate investment trust (REIT) headquartered in Winter Park, Florida. Investor Deadline: Investors who purchased or acquired CTO securities between February 18, 2021 through June 24, 2025 (the "Class Period") may, no later than October 7, 2025, seek to be appointed as a lead...
2025-08-20 12:36 PM EDT
NOVO NORDISK A/S SECURITIES FRAUD NOTICE: Berger Montague Informs Novo Nordisk A/S (NVO) Investors of Securities Fraud Lawsuit
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Novo Nordisk A/S. (NYSE: NVO) ("Novo" or the "Company") following the filing of a securities class action lawsuit. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Novo securities from May 7, 2025 through July 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Novo...
2025-08-20 12:21 PM EDT
DEADLINE APPROACHING: Berger Montague Advises Petco Health and Wellness Company (WOOF) Investors to Inquire About a Securities Fraud Class Action by August 29, 2025
Philadelphia, Pennsylvania--(Newsfile Corp. - August 20, 2025) - Berger Montague, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF). A class action lawsuit was recently filed on behalf of investors who acquired Petco securities between January 14, 2021 and June 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired...
2025-08-20 12:11 PM EDT
SOC CLASS ACTION NOTICE: Berger Montague Encourages Sable Offshore Corp. (SOC) Investors to Inquire About a Securities Fraud Class Action
Philadelphia, Pennsylvania--(Newsfile Corp. - August 19, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Sable Offshore Corp. (NYSE: SOC) ("Sable" or the "Company"), an offshore oil and gas operations company headquartered in Houston, Texas, after a class action lawsuit was filed against Sable. Investor Deadline: Investors who purchased or acquired Sable securities between May 19, 2025 through June 3, 2025 (the "Class Period"), including on or...
2025-08-19 9:06 PM EDT
ATTENTION ALT INVESTORS: Contact Berger Montague About an Altimmune, Inc. Class Action Lawsuit
Philadelphia, Pennsylvania--(Newsfile Corp. - August 19, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis) after a class action lawsuit was filed against Altimmune. Investor Deadline: Investors who purchased or...
2025-08-19 3:36 PM EDT